Nykode Therapeutics AS (OSL:NYKD)

Norway · Delayed Price · Currency is NOK

3.380

+0.030 (0.90%)

Aug 4, 2026, 4:27 PM CET

Nykode Therapeutics AS Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.45	0.45	9.16	13.32	9.03	35.77
Revenue Growth	-95.05%	-95.05%	-31.26%	47.56%	-74.76%	-83.42%
Gross Profit	0.45	0.45	9.16	13.32	9.03	35.77
Operating Income	-28.59	-28.59	-48.33	-58.08	-53.16	-10.78
Net Income	-12.24	-12.24	-38.82	-35.15	-42.74	-9.41
Earnings Per Share	-0.04	-0.04	-0.12	-0.12	-0.15	-0.03
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	60.29	60.29	115.4	162.6	206.39	228.4
Total Debt	2.55	2.55	3.44	5.73	5.51	7.17
Net Cash (Debt)	57.74	57.74	111.96	156.88	200.87	221.23
Net Cash Growth	-48.43%	-48.43%	-28.63%	-21.90%	-9.20%	6.10%
Net Cash Per Share	0.18	0.18	0.34	0.52	0.69	0.77

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-29.46	-29.46	-51.22	-96.62	-20.69	1.16
Capital Expenditures	-0.04	-0.04	-0.07	-1.9	-2.68	-0.87
Free Cash Flow	-29.49	-29.49	-51.29	-98.53	-23.37	0.28
Free Cash Flow Growth	-	-	-	-	-	-99.84%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-6310.82%	-6310.82%	-527.75%	-435.95%	-588.73%	-30.13%
Pretax Margin	-3906.62%	-3906.62%	-496.98%	-330.90%	-564.66%	-31.09%
Profit Margin	-2701.99%	-2701.99%	-423.90%	-263.86%	-473.40%	-26.32%
FCF Margin	-6510.82%	-6510.82%	-560.07%	-739.52%	-258.81%	0.79%

Dividends

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Aug '26 Aug 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Dividend Per Share	1.000	-	0.088
Dividend Per Share Growth	-	-	-
Dividend Yield	29.85%	41.20%	0.00%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	24.28	24.28	24.28	23.99	4.32
P/FCF Ratio	-	-	-	-	-	9334.41
PS Ratio	203.83	172.94	9.58	51.10	94.11	74.12